359 related articles for article (PubMed ID: 27649560)
21. Hyperplastic and neoplastic lesions of the mammary gland in macaques.
Wood CE; Usborne AL; Starost MF; Tarara RP; Hill LR; Wilkinson LM; Geisinger KR; Feiste EA; Cline JM
Vet Pathol; 2006 Jul; 43(4):471-83. PubMed ID: 16846989
[TBL] [Abstract][Full Text] [Related]
22. The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas.
Klopfleisch R; Lenze D; Hummel M; Gruber AD
Vet J; 2011 Nov; 190(2):236-243. PubMed ID: 21112801
[TBL] [Abstract][Full Text] [Related]
23. Growth hormone receptor (GHR) RNAi decreases proliferation and enhances apoptosis in CMT-U27 canine mammary carcinoma cell line.
Pawłowski KM; Popielarz D; Szyszko K; Gajewska M; Motyl T; Król M
Vet Comp Oncol; 2012 Mar; 10(1):2-15. PubMed ID: 22235976
[TBL] [Abstract][Full Text] [Related]
24. Technical validation of an RT-qPCR in vitro diagnostic test system for the determination of breast cancer molecular subtypes by quantification of ERBB2, ESR1, PGR and MKI67 mRNA levels from formalin-fixed paraffin-embedded breast tumor specimens.
Laible M; Schlombs K; Kaiser K; Veltrup E; Herlein S; Lakis S; Stöhr R; Eidt S; Hartmann A; Wirtz RM; Sahin U
BMC Cancer; 2016 Jul; 16():398. PubMed ID: 27389414
[TBL] [Abstract][Full Text] [Related]
25. DNA Methylation Status of the Estrogen Receptor α Gene in Canine Mammary Tumors.
Brandão YO; Toledo MB; Chequin A; Cristo TG; Sousa RS; Ramos EAS; Klassen G
Vet Pathol; 2018 Jul; 55(4):510-516. PubMed ID: 29566609
[TBL] [Abstract][Full Text] [Related]
26. Prolactin binding in benign and malignant mammary tissue of female dogs.
Rutteman GR; Willekes-Koolschijn N; Bevers MM; Van der Gugten AA; Misdorp W
Anticancer Res; 1986; 6(4):829-35. PubMed ID: 3019223
[TBL] [Abstract][Full Text] [Related]
27. Human basal-like breast cancer is represented by one of the two mammary tumor subtypes in dogs.
Watson J; Wang T; Ho KL; Feng Y; Mahawan T; Dobbin KK; Zhao S
Breast Cancer Res; 2023 Oct; 25(1):114. PubMed ID: 37789381
[TBL] [Abstract][Full Text] [Related]
28. Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.
Ettlin J; Clementi E; Amini P; Malbon A; Markkanen E
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531107
[TBL] [Abstract][Full Text] [Related]
29. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
30. Expression and molecular characterization of the growth hormone receptor in canine mammary tissue and mammary tumors.
van Garderen E; van der Poel HJ; Swennenhuis JF; Wissink EH; Rutteman GR; Hellmén E; Mol JA; Schalken JA
Endocrinology; 1999 Dec; 140(12):5907-14. PubMed ID: 10579357
[TBL] [Abstract][Full Text] [Related]
31. [Hormone receptor determination in breast carcinoma tissue. Comparison of recent immunohistologic techniques with biochemical receptor testing].
Wilkens C; Beck T; Weikel W; Brumm C; Pollow K
Pathologe; 1995 Jul; 16(4):256-61. PubMed ID: 7667207
[TBL] [Abstract][Full Text] [Related]
32. PD-L1 mRNA and protein expression in canine mammary carcinomas: Correlation with histopathological grade and molecular markers.
Bae MK; Ko YU; Seung BJ; Sur JH; Choe NH
Vet Pathol; 2024 May; 61(3):402-409. PubMed ID: 38281145
[TBL] [Abstract][Full Text] [Related]
33. Immunohistochemical detection of progesterone and cellular proliferation in canine mammary tumours.
Thuróczy J; Reisvaag GJ; Perge E; Tibold A; Szilágyi J; Balogh L
J Comp Pathol; 2007; 137(2-3):122-9. PubMed ID: 17645888
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical study of the expression of E-cadherin in canine mammary tumours.
Reis AL; Carvalheira J; Schmitt FC; Gärtner F
Vet Rec; 2003 May; 152(20):621-4. PubMed ID: 12790166
[TBL] [Abstract][Full Text] [Related]
35. Reliable PCR quantitation of estrogen, progesterone and ERBB2 receptor mRNA from formalin-fixed, paraffin-embedded tissue is independent of prior macro-dissection.
Tramm T; Hennig G; Kyndi M; Alsner J; Sørensen FB; Myhre S; Sørlie T; Overgaard J
Virchows Arch; 2013 Dec; 463(6):775-86. PubMed ID: 24100522
[TBL] [Abstract][Full Text] [Related]
36. Expression of TopBP1 in canine mammary neoplasia in relation to histological type, Ki67, ERalpha and p53.
Morris JS; Nixon C; King OJ; Morgan IM; Philbey AW
Vet J; 2009 Mar; 179(3):422-9. PubMed ID: 18314357
[TBL] [Abstract][Full Text] [Related]
37. PKM2 in Canine Mammary Tumors: Parallels to Human Breast Cancer.
Lee HJ; Han HJ; Lee JY; Son WC
Comp Med; 2020 Aug; 70(4):349-354. PubMed ID: 32718384
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of immunohistochemical markers and histological classification in malignant canine mammary tumours.
Pastor N; Ezquerra LJ; Santella M; Caballé NC; Tarazona R; Durán ME
Vet Comp Oncol; 2020 Dec; 18(4):753-762. PubMed ID: 32336005
[TBL] [Abstract][Full Text] [Related]
39. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome.
Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A
Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215
[TBL] [Abstract][Full Text] [Related]
40. Histological and immunohistochemical identification of atypical ductal mammary hyperplasia as a preneoplastic marker in dogs.
Ferreira E; Gobbi H; Saraiva BS; Cassali GD
Vet Pathol; 2012 Mar; 49(2):322-9. PubMed ID: 21282668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
